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Progress in the biology of myo-inositol hexakisphosphate (InsP6) has been delayed by the lack of a quantitative description of its
multiple interactions with divalent cations. Our recent initial description of these [J. Torres, S. Dominguez, M.F. Cerda, G. Obal, A.
Mederos, R.F. Irvine, A. Diaz, C. Kremer, J. Inorg. Biochem. 99 (2005) 828–840] predicted that under cytosolic/nuclear conditions, pro-
tein-free soluble InsP6 occurs as Mg5(H2L), a neutral complex that exists thanks to a signiﬁcant, but undeﬁned, window of solubility
displayed by solid Mg5(H2L) Æ 22H2O (L is fully deprotonated InsP6). Here we complete the description of the InsP6–Mg
2+–Ca2+ system,
deﬁning the solubilities of the Mg2+ and Ca2+ (Ca5(H2L) Æ 16H2O) solids in terms of Ks0 = [M
2+]5[H2L
10], with pKs0 = 32.93 for
M =Mg and pKs0 = 39.3 for M = Ca. The concentration of soluble Mg5(H2L) at 37 C and I = 0.15 M NaClO4 is limited to 49 lM,
yet InsP6 in mammalian cells may reach 100 lM. Any cytosolic/nuclear InsP6 in excess of 49 lM must be protein- or membrane-bound,
or as solid Mg5(H2L) Æ 22H2O, and any extracellular InsP6 (e.g. in plasma) is surely protein-bound.
 2006 Elsevier Inc.
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Open access under CC BY license.1. Introduction
myo-Inositol hexakisphosphate (InsP6, derived from
inositol hexaphosphoric acid C6H18O24P6, abbreviated in
this work as H12L) is an ubiquitous and abundant meta-
bolite in eukaryotic cells (reviewed in [1–3]). It is the
precursor of at least two inositol pyrophosphates; these less
abundant, fast-turnover metabolites, have been assigned a
variety of functions including the regulation of membrane0162-0134  2006 Elsevier Inc.
doi:10.1016/j.jinorgbio.2006.06.016
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Open access under CC BY license.traﬃcking, telomere length, and membrane–protein inter-
actions involved in chemotaxis (reviewed in [4]). However,
the functions of InsP6 itself are still poorly understood. In
mammalian cells, it is a necessary cofactor for the repair of
double-stranded breaks in DNA, through the binding of
the Ku component of DNA-PK, and is necessary for
RNA editing events, through its binding of some of the
adenosine deaminase enzymes [5–8]. In yeasts, the com-
pound is necessary for mRNA export from the nucleus,
through as yet undeﬁned protein targets [9–11]. In
addition, InsP6 may contribute to localise PDK-1 to the
cytosol, by competing for the enzyme’s PH domain with
plasma membrane phosphoinositides [12]. InsP6 concentra-
tions in animal and yeast cells are not thought to undergo
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the three functions mentioned above are apparently
fulﬁlled by basal concentrations of InsP6. In plant cells,
InsP6 levels can have signiﬁcant signalling roles by regulat-
ing K+ and Ca2+ ﬂuxes [13,14]. In addition, a major
function of InsP6 in plants is to give rise to deposits for
the storage of phosphorus and metal cations, as further
discussed below.
In addition to the apparently unconnected set of roles
mentioned above, InsP6 has been assigned a bewildering
number of other biological functions as well as pharmaco-
logical actions. This has been critically reviewed by Shears
who pointed out that a number of the proposals in the lit-
erature may arise from experimental artefacts [2]. Indeed, it
is easy to run into artefacts when carrying out biological
experiments with InsP6. This stems from: (i) the compound
being abundant, and so including high concentrations of it
in experiments is initially justiﬁed, and (ii) its chemistry
of interaction with divalent cations being complicated,
non-intuitive, and so far poorly described. This chemistry
encompasses solution complexation and precipitation
reactions. Complexation can deplete solutions of divalent
cations, while precipitation (easily unnoticed when working
with small volumes) can not only deplete divalent cations,
but also acidify the solutions and interfere with assays
per se.
Equally seriously, the lack of understanding of InsP6
chemistry means that the physical and chemical forms
of the compound in cells are still partially obscure. This
problem is compounded by the questions about the cellu-
lar distribution of InsP6. Most InsP6 in mammalian cells
is thought to be cytosolic and/or nuclear [15]. In addition,
in plants [16–18], and in a particular (invertebrate) animal
system [19,20], the compound occurs in vesicular/vacuolar
and/or extracellular compartments, there appearing as
‘‘phytate deposits’’, i.e. InsP6 salts with monovalent, and
mostly divalent, cations. Speculations on the status of
InsP6 in mammalian cells encompass the possible exis-
tence of vesicular pools as well as of insoluble deposits
in cytosol (see for example [15,21]). In addition, dietary
InsP6 has been shown to be absorbed in the intestine, cir-
culate in plasma, and to be excreted in urine (reviewed in
[22]).
The chemistry of InsP6 in solution in the presence of
divalent cations has been addressed in several works (see
in particular [23,24]). However, this chemistry was only
comprehensively described, and its biological consequences
directly inferred, in our recent study [25]. A major feature
of this chemistry is that InsP6 forms high-aﬃnity com-
plexes of 1:1 stoichiometry with divalent (and trivalent)
cations; this is the dominant behaviour when InsP6 is in
molar excess with respect to cation(s). A further, biologi-
cally signiﬁcant, feature of the solution chemistry is that
InsP6 also forms, in the presence of molar excess of
Mg2+, the neutral soluble species Mg5(H2L) (where L
denotes fully deprotonated InsP6). Under cytosolic or
nuclear conditions, all soluble InsP6 not bound to proteinsor other organic components is predicted to be found in
this form (InsP6 binds at least certain proteins bearing very
basic sites in Mg2+-free form [8]). Although we veriﬁed
experimentally that relevant concentrations of Mg5(H2L)
could exist under cytosolic/nuclear conditions, the species
is only sparingly soluble; in fact, isolation of the corre-
sponding solid, Mg5(H2L) Æ 22H2O, was straightforward
[25]. The signiﬁcant (though small) solubility of Mg5(H2L)
is a peculiarity, not displayed by other divalent cations,
Ca2+ included: the dominant aspect of InsP6 chemistry
under molar excess of the divalent (or trivalent) cations is
the formation of solids.
The limited solubility of its presumed cytosolic form
Mg5(H2L), plus the proven formation of solids by InsP6
in certain biological contexts (and the possibility of this tak-
ing place in others), call for a quantitative description of the
solubility behaviour of this metabolite. The experimental
problems (described above) arising from not being able to
predict this behaviour also call for such a study, and this
in turn requires the stoichiometries of the solids to be
known. Stoichiometries reported for the divalent metal sol-
ids of InsP6 range from 4:1 to 6:1 (metal:InsP6 ratios); the
5:1 ratio, as we found for the Mg2+ solid [25], is the one
reported most often [23,24,26–29]. The precipitation equi-
libria are tied to the complexation and protonation equilib-
ria in solution, so the quantitative description of these [25] is
also needed to describe the solubility behaviour. In the pres-
ent work, we have determined the stoichiometry of the Ca2+
salt of InsP6; together with the data in our previous work,
this allowed us to translate analytical measurements of total
Ca and Mg at equilibrium with the solid phytates into sol-
ubility product constants for the two salts. Therefore a full
description of the InsP6–Ca
2+–Mg2+ system has resulted.
The data put an upper limit to the concentration of InsP6
that can exist in cytosol or nucleus of mammalian cells in
protein-free, soluble form, a limit that is within the range
of available estimates of the total InsP6 concentration in
cells. Our data also indicate that protein-free extracellular
InsP6 cannot exist in solution. In addition, we have been
able to summarise the complex and non-intuitive solubility
behaviour of InsP6 in a series of plots that indicate clearly
whether total, partial or nil solubility is to be expected
across a wide range of conditions.
2. Experimental
2.1. Chemicals
All common laboratory chemicals were reagent grade,
purchased from commercial sources and used without fur-
ther puriﬁcation. CaCl2 Æ 2H2O, and MgCl2 Æ 6H2O, were
used as metal sources. Phytate solutions for the synthesis
of the complexes were prepared by dilution of a phytic acid
solution in water (40 wt.%; Aldrich). Solutions were used
immediately after preparation. Ultrapure water obtained
from a Millipore-MilliQ plus system was used throughout
this work.
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analysis
Infrared spectroscopy was carried out on a Bomen FT-
IR spectrophotometer, with samples present as KBr (1%)
pellets. Thermal analysis was performed on a Shimadzu
DTA-50, TGA-50 instrument with a TA 50I interface,
using a platinum cell and nitrogen atmosphere. Experimen-
tal conditions were 1 C min1 temperature ramp rate and
50 mL min1 nitrogen ﬂow rate.
Elemental analysis (C, H) was performed on aCarlo Erba
EA 1108 instrument. Na and K were determined by atomic
absorption spectroscopy on a Perkin–Elmer 5000 instru-
ment. Ca content was determined gravimetrically as CaC2O4
as follows: calcium phytate was dissolved in 2 M HCl and
100% excess of H2C2O4 Æ 2H2O was added and the pH of
the solution was raised with NH4OH (7.4 M) up to 1.5–3.0.
Calcium oxalate then precipitated, and was washed with
water (2 · 5 mL), centrifugued, and dried at 70 C for 12 h.
2.3. Synthesis of [Mg5(H2L)] Æ 22H2O and
[Ca5(H2L)] Æ 16H2O
The magnesium compound was prepared as previously
reported [25]. Preparation of [Ca5(H2L)] Æ 16H2O followed
a similar procedure. An aqueous solution of InsP6
(0.01 M) was prepared and its pH adjusted to 10–11 by
addition of LiOH (1 M). To this solution (30 mL;
0.3 mmol), CaCl2 Æ 2H2O (0.22 g; 1.5 mmol) dissolved in
the minimum amount of water was added. A white solid
immediately appeared, which was separated by centrifuga-
tion, thoroughly washed with water (3 · 10 mL), and dried
with ethanol (2 · 10 mL). Yield was 37% (126 mg). Ele-
mental analysis calcd (%) for Ca5C6H40O40P6 (1138.59):
C 6.3, H 3.5, Ca 17.6; found C 6.4, H 3.3, Ca 17.7. Thermal
analysis agreed with the proposed formula: 25.3% weight
loss corresponding to the elimination of water, compared
with a calculated value of 25.6%. IR (KBr pellets)
m = 3447 (mO–H), 1114 (mP–O), 545 (qw, H2O) cm
1.Table 1
Determination of pKs0 for Mg and Ca phytates
a
Cation H+ added (lmol) [M2+]tot (mM) [InsP6]tot (mM)
Mg 4.89 0.781 0.156
19.6 1.84 0.369
19.6 1.83 0.366
19.6 1.83 0.366
Ca 193.7 9.83 1.97
193.7 9.48 1.90
193.7 10.0 2.00
193.7 9.31 1.86
193.7 9.95 1.99
193.7 9.38 1.88
a ‘‘H+ added’’ represents the amount of protons in the volume of acid added
or Ca determined in the saturated solution. [InsP6]tot corresponds to 1/5 the am
amount of InsP6, both according to the stoichiometry of the solid phytates prev
concentrations calculated using HySS software. The pKs0 values are valid for2.4. Solubility measurements
Solubility measurements were carried out at constant
ionic strength I = 0.15 M NaClO4, and 37.0 C. Approxi-
mately 50 mg of the compound (Mg or Ca phytate) was
suspended in 0.15 M aqueous NaClO4 (Mg, 20.0 mL; Ca,
15.0 mL). Known amounts of HCl were added, so as to
reach equilibrium points corresponding to measurable
amounts of metal in solution (Table 1). Each mixture
was kept in a glass jacketed cell under continuous stirring
until measured pH was constant (ca. one week). After the
equilibrium was reached, excess solid was ﬁltered out
(Macherey–Nagel MN 640 m paper), and the metal con-
centration was determined in the supernatant. Mg was
determined volumetrically according to standard tech-
niques [30]. Ca was determined as described in Section
2.2. With these M2+ concentration values, and assuming
a 5:1:2 stoichiometry (M2+:InsP6:H
+), total amounts of
InsP6 were calculated. Then total concentrations of M
2+,
InsP6 and H
+ were used as inputs in the HySS software
[34] to determine the equilibrium concentrations of (free)
M2+ and H2L
10, which deﬁne the Ks0. In this calculation,
the complete set of equilibria involved [25] was taken into
account. At least four independent determinations were
performed for each metal.
3. Results and discussion
3.1. Stoichiometry of calcium and magnesium phytates
As mentioned, previous works dealing with the interac-
tion of M2+ ions with InsP6 under metal excess report the
formation of very insoluble compounds having M2+:InsP6
ratios of 4:1, 5:1 or 6:1 [23–29]. The solids contain large
amounts of crystallization water, which hampers their full
characterization. An additional feature reported is the
presence of mixed salts containing two cations (for example
Ca and Na, Ca and Zn, etc.) [31–34] or two anions (Cl
and InsP6) [23].[H+]tot (mM) [M
2+]free (M) [H2L
10]free (M) pKs0
0.556 4.01 · 104 1.29 · 1016 32.87
1.71 1.28 · 103 3.41 · 1019 32.93
1.70 1.28 · 103 3.32 · 1019 32.95
1.70 1.28 · 103 3.32 · 1019 32.95
15.3 7.88 · 103 2.22 · 1029 39.2
15.2 7.61 · 103 1.57 · 1029 39.4
15.4 8.02 · 103 2.43 · 1029 39.1
15.1 7.48 · 103 1.35 · 1029 39.5
15.4 7.98 · 103 2.27 · 1029 39.1
15.2 7.53 · 103 1.39 · 1029 39.5
at the start of the saturation runs. [M2+]tot is the total concentration of Mg
ount of M2+, while [H+]tot is calculated as [H
+]added plus two times the total
iously determined. [M2+]free and [H2L
10]free correspond to free equilibrium
I = 0.15 M NaClO4 and 37 C.
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techniques the salt [Mg5(H2L)] Æ 22H2O [25]. In our hands,
the calcium analogue formed under straightforward condi-
tions ﬁtted perfectly this same (5:1) stoichiometric ratio.
The solid incorporated 16 water molecules, thus respond-
ing to the formula [Ca5(H2L)] Æ 16H2O. The presence of a
large amount of crystallized solvent was qualitatively evi-
dent from the strong and broad absorption in the IR spec-
trum at 3447 cm1. Quantiﬁcation of water content by
thermogravimetric analysis showed that the sixteen water
molecules were lost across a wide temperature range,
namely between 50 and 210 C.
To assess whether the Mg2+ and Ca2+ solids can change
their compositions in the presence of Na+ or K+, we per-
formed the syntheses as described in Section 2 but in media
containing either 0.15 M NaClO4 or 0.15 M KCl. The sol-
ids so obtained agreed perfectly with the expected formula
½MII5 ðH2LÞ  xH2O. Na or K determinations by atomic
absorption demonstrated that only residual amounts (i.e.
less than 0.1% molar ratio with respect to M2+) of the alka-
line cations were present, probably as occluded chloride
salts not eliminated during the washing procedure. Thus
the formation of mixed cation compounds with ﬁxed
M2+/Na or M2+/K stoichiometries can be ruled out under
these experimental conditions.3.2. Solubility product constants of calcium and
magnesium phytates
Mg and Ca phytates are only sparingly soluble in water.
Given their stoichiometries, the solubilities of these solids
will be governed by solubility product constants with the
form: Ks0 = [M
2+]5[H2L
10]; the constant Ks0 depends only
on the temperature. It is easy to appreciate that precipita-
tion of Mg or Ca phytate depends strongly on the concen-
tration of free Ca2+ or Mg2+ in the system. Moreover, it
further depends on the concentration of di-protonated phy-
tate, H2L
10. This is very much a minority species for sol-
uble InsP6 under most conditions, the dominant species
being the less highly charged ones, in which the anion is
associated with more protons, and/or monovalent and/or
divalent cations [25]. This notwithstanding, with other con-
ditions ﬁxed, the concentration of H2L
10 (a highly depro-
tonated species) can be expected to increase as pH isTable 2
Calculated solubility of [Mg5(H2L)] Æ 22H2O and [Ca5(H2L)] Æ 16H2O in 0.15 M
pH Solubility (M)
[Mg5(H2L)] Æ 22H2O [Ca5(H2L)] Æ 16H2O
2.5 3.08 · 102 1.75 · 103
5.0 4.77 · 104 2.05 · 105
6.0 1.65 · 104 4.71 · 106
7.0 9.10 · 105 1.28 · 106
7.5 7.73 · 105 7.26 · 107
8.0 6.96 · 105 4.36 · 107
10.0 6.06 · 105 1.27 · 107increased. This rationalises the straightforward observation
that phytates are more soluble under acidic than under
basic conditions. A closely related point is that the precip-
itation of phytates will tend to acidify the solutions in
which it takes place. For example, the dominant InsP6 spe-
cies in solution in the absence of divalent cations and at
neutral pH have three and four protons [25]. Addition of
suﬃcient calcium or magnesium removes, through precipi-
tation, H2L
10 from solution. This species is in turn replen-
ished at the expense of the more highly protonated forms
of soluble InsP6, with the release of protons into solution.
Determination of the Ks0 values obviously requires mea-
suring sets of values for the concentrations of H2L
10 and
of free metal at equilibrium with the solids. These can in
turn be calculated from the straightforward analytical data
by means of an appropriate software such as HySS [35] fed
with the complete set of equilibrium constants for the pro-
tonation and complexation equilibria [25]. We thus equili-
brated the solid phytates with unbuﬀered, M2+-free, dilute
acid at 37.0 C and under physiological ionic strength.
Then total Ca or Mg in solution were determined, and
the amounts of InsP6 that went into solution calculated
as 1/5 the former ﬁgures. From the total concentration of
InsP6, M
2+, and total exchangeable protons present in
the solution, the HySS software calculated concentrations
of H2L
10 and of free metal, yielding in turn estimations
for pKs0 (i.e. logKs0). The results shown in Table 1 can
be summarised in the solubility products:
½Mg5ðH2LÞ $ 5Mg2þ þH2L10; pKs0 ¼ 32:93ð6Þ;
½Ca5ðH2LÞ $ 5Ca2þ þH2L10; pKs0 ¼ 39:3ð4Þ;
which are valid at I = 0.15 M NaClO4 and 37.0 C.
The higher pKs0 value for Ca reﬂects the lower solubility
of Ca phytate in comparison to its Mg analogue. With
these values in hand, it was possible to calculate the solubil-
ity of both compounds in water at diﬀerent pH values
(under physiological ionic strength and in the absence of
added Ca2+ or Mg2+), as shown in Table 2.
3.3. A complete description of the behaviour of the InsP6
in the presence of Ca2+ and Mg2+
The pKs0 values for the solid phytates, together with the
protonation and Ca and Mg complexation constants inNaClO4 and 37.0 C at diﬀerent pH values
Solubility (mg/L)
[Mg5(H2L)] Æ 22H2O [Ca5(H2L)] Æ 16H2O
35969 1993
557 23.3
192 5.36
106 1.46
90.2 0.83
81.2 0.50
70.8 0.14
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description of the behaviour of InsP6 in the presence of
Ca2+ and/or Mg2+. Since this is a system comprising 22
equilibrium equations, it can only be handled by specialised
software such as HySS [35].
Fig. 1 summarises the behaviour of InsP6 in the presence
of Ca2+. It can be seen that at pH 7.5 Ca2+ causes InsP6 to
fall out of solution even at very low concentrations of the
polyphosphate. At a ﬁxed total calcium concentration, as
the total InsP6 concentration is raised, the abundance of
the solid phytate increases, reaching a maximum near
to the stoichiometric (5:1) calcium:InsP6 ratio. As InsP6
concentration is increased beyond this point, the solid
(Fig. 1a) is gradually replaced by the soluble 1:1 complexes
(Fig. 1b). This is the ‘‘paradoxical’’ solubility behaviour ofFig. 1. Behaviour of InsP6 in the presence of calcium. The graphs show the p
diﬀerent soluble, 1:1, Ca:InsP6 complexes (b, d), plotted against total concentr
‘‘zoom-in’’ of the range up to 0.1 mM total InsP6. Predictions are drawn for pH
that the abundance scales in diﬀerent parts are diﬀerent.InsP6, whereby for some concentration ranges, adding
InsP6 to a partially insoluble system causes it to become
fully soluble. This behaviour can be rationalised on the
basis of the excess InsP6 acting, through the formation of
the soluble 1:1 complexes, as a calcium sequestering agent.
Thus in this context the addition of excess InsP6 is analo-
gous to the addition of EDTA (ethylenediaminetetraace-
tate), the system’s solubility being therefore caused by the
absence of free Ca2+. The broad features of the InsP6-cal-
cium system do not vary to a great extent with pH, except
for strongly acidic conditions, i.e. pH 3 and below. For
these acidic conditions, the range of dominance of solid
phytate shrinks, with a concomitant increase in the domi-
nance range of the 1:1 complexes (Fig. 1c and d). This is
the consequence of the linked equilibria established byredicted abundances of solid calcium phytate (a, c) and of the sum of the
ations of InsP6 (0–5 mM) and Ca
2+ (0.1–5 mM). The inset in (a) shows a
7.5 (a, b) and pH 3.0 (c, d), always in 0.15 M NaClO4 and 37.0 C. Note
Fig. 2. Behaviour of InsP6 in the presence of magnesium. The graphs show the predicted abundances of solid magnesium phytate (a, d), of the soluble 5:1
complex (b, e), and of the sum of the diﬀerent soluble 1:1 complexes (c, f), all plotted against total concentrations of InsP6 (0–5 mM) and Mg
2+ (0.1–
5 mM). Predictions are drawn for pH 7.5 (a–c) and pH 4.5 (d–f), always in 0.15 M NaClO4 and 37.0 C. The inset in (a) shows a ‘‘zoom-in’’ of the range up
to 0.1 mM total InsP6. Note that the abundance scales for (b) and (e) are diﬀerent from the rest.
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Fig. 3. Behaviour of InsP6 in the presence of calcium and magnesium. In
(a), the predicted abundance of solid calcium and magnesium phytates is
plotted, for a ﬁxed total InsP6 concentration of 1 mM and pH 7.5, against
total Ca2+ and Mg2+ concentrations. The plot in (b) shows the behaviour
of the system at a total InsP6 concentration (50 lM) near the solubility
limit of magnesium phytate, in the presence of 150 lM Ca2+, also at pH
7.5; note that the presence of Mg2+ confers solubility to an otherwise
insoluble system. Predictions are for I = 0.15 M NaClO4 and 37.0 C.
Note that ‘‘(s)’’ in graph labels stands for ‘‘solid’’.
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10 towards the
more highly protonated species as well as the 1:1 complexes
that these can form with Ca2+.
The behaviour in the presence of Mg2+ is slightly more
complex. This is due to the 5:1 species having a signiﬁcant
window of solubility, a feature that is undetectable in
the case of Ca2+ [25]. Thus under Mg:InsP6 excess, the
dominant species in solution is the neutral 5:1 complex.
However, beyond a certain concentration, this species
precipitates, as [Mg5(H2L)] Æ 22H2O. Hence, to summarise
the behaviour of the InsP6–Mg
2+ system, three major
forms need to be considered: the solid, the soluble 5:1
species, and the soluble 1:1 complexes (Fig. 2). With respect
to the solid and the soluble 1:1 complexes, the overall
behaviour is similar to that described previously for Ca2+
(Fig. 2a and c). However, the lower pKs0 of the system is
reﬂected in a signiﬁcant region of full solubility even under
conditions of metal excess (compare Fig. 2a, inset with
Fig. 1a, inset); in this window, virtually all of the InsP6 is
present as the soluble neutral 5:1 species (Fig. 2b). Interest-
ingly, the concentration of this soluble 5:1 complex has an
upper limit at 49 lM, as ﬁgure that is ﬁxed, irrespective of
total InsP6 concentration, size of the Mg
2+ excess, or pH.
Mathematically, this is the consequence of the fact that
multiplying the expression for the equilibrium constant
for the formation of the soluble 5:1 complex [25]
K ¼ ½Mg5ðH2LÞ=ð½Mg2þ5½H2L10Þ
by the expression for the solubility product constant
Ks0 ¼ ½Mg2þ5½H2L10
yields
K  Ks0 ¼ ½Mg5ðH2LÞðaqÞ ¼ 4:9 105:
In other words, the concentration of soluble penta-
magnesium species at equilibrium with solid magnesium
phytate is a constant at a given temperature. Under condi-
tions of Mg2+ excess, increasing total InsP6 beyond 49 lM
always means that the concentration of the soluble penta-
magnesium complex also breaks the 49 lM barrier, and
hence solid magnesium phytate starts to accumulate
(Fig. 2a and b). The overall behaviour of the Mg2+–InsP6
system is fairly invariant for pH values above 6. However,
at acidic pH values the ranges of formation of the soluble
and solid 5:1 species shrink. This behaviour is similar to
that of the Ca2+ system but more pronounced, being very
marked already at pH 4.5 (Fig. 2d–f).
The behaviour of the system with both Ca2+ and Mg2+
present is broadly similar to the single-metal ones just
described, as long as the concentrations of the two cations
are considered together. As previously described, molar
excesses of cation over InsP6 are accompanied by precipita-
tion, while molar excesses of InsP6 result in soluble 1:1 com-
plexes. Within the range of formation of the solids, the more
insoluble calcium phytate dominates over its magnesium
counterpart. Notwithstanding, as long as the Ca2+:InsP6ratio is less than 5, and Mg2+ is abundant, magnesium phy-
tate does precipitate together with calcium phytate (Fig. 3a).
For InsP6 concentrations below 49 lM and similar concen-
trations of Ca2+, the presence of excess Mg2+ actually con-
fers solubility to the system, as InsP6 is drawn towards the
soluble pentamagnesium complex (Fig. 3b).
3.4. Predictions for InsP6 under cytosolic and nuclear
conditions
The chemical data presented above make it possible to
predict the speciation of InsP6 under biological conditions.
The most relevant of these conditions are those of cytosol
and nucleus, in which most or all of the InsP6 in typical
animal cells is probably present [15]. In our previous paper
[25], to simulate cytosolic/nuclear conditions we had set the
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[37]; Ca2+ signals were taken into account by including
total Ca2+ concentrations of up to 10 lM (reviewed in
[38]). Those calculations indicated that all InsP6 not bound
to protein and/or membranes existed as the pentamagne-
sium complex [25]. At the time we did not have the solubil-
ity product constants, and so we stated that the validity of
our predictions was restricted to the solubility range of
magnesium phytate. When predictions including the pre-
cipitation equilibria are run for the set of conditions
detailed above and InsP6 concentrations between 1 and
100 lM, the following results are obtained: (i) there is no
association with Ca2+, whether in solution or in the solid
phase; (ii) up to a total concentration of 49 lM, InsP6 is
present exclusively as the soluble pentamagnesium com-
plex; (iii) any InsP6 in excess of 49 lM, is present as solid
magnesium phytate. Therefore our previous predictions
are conﬁrmed, but a complication arises as a result of the
limited solubility of Mg5(H2L).
Estimations of total InsP6 concentrations in mammalian
cells are mostly in the 10–60 lMrange, with data from some
cell lines going up to 105 lM[39–45].As these estimations do
not take cell compartmentalisation into account, actual con-
centrations are probably higher. It is conceivable that InsP6
in cells is at equilibrium with its solid magnesium salt – note
that massive amounts of solid magnesium InsP6 exist in a
peculiar biological system, namely within specialised cells
of the dispersal larva of the mesozoan Dicyema typus [46].
However, we envisage as the more likely possibility that
the InsP6 pool available for the formation of Mg5(H2L) is
kept below 49 lM in typical eukaryotic cells. From this
standpoint, any InsP6 in excess of this ﬁgure would be bound
to cellular components such as proteins and/or cell mem-
branes [47]. Polyamines are unlikely to contribute sub-
stantially to the InsP6-binding capacity of the cell. This
reasoning is based on the facts that: (i) once association with
nucleic acids and nucleotides is taken into account, the
remaining pools of spermidine and spermine are relatively
small [48], and (ii) InsP6 aﬃnity constants reported for poly-
amines are not large enough for eﬀective competition with
the more abundant Mg2+, except in the case of the tri-
protonated forms of polyamines, which represent only a
minor proportion at physiological pH [49].
In summary, our data suggest that InsP6 in the cytosol
and nucleus of mammalian cells is close to the saturation
of its solubility. Therefore the manipulation of cells so as
to increase their InsP6 concentrations to a signiﬁcant extent
(e.g. [50–52]) probably causes the intracellular precipitation
of magnesium phytate. It is worth commenting at this point
that although, asmentioned, InsP6 has a second range of sol-
ubility at concentrations inmolar excess with respect to total
Mg2+ plus Ca2+, these conditions are non-physiological, as
they entail the complete absence of free divalent cations.
The case of slime molds deserves a special mention is
this context. The overall concentration of InsP6 in Dictyos-
telium discoideum amoebae has been estimated at 0.7 mM
[53]; no information on the intracellular distribution ofthe compound is available. Our data predict that whatever
its localisation, most of this InsP6 must be present in a
physicochemical form other than the soluble pentamagne-
sium species. It seems likely that InsP6 in D. discoideum
may form deposits in so-called ‘‘mass-dense granules’’ or
‘‘polyphosphate bodies’’; these are acidic organelles rich
in P, Mg and Ca, which are now known to be intimately
related to the contractile vacuoles [54–57]. Phosphorus in
these granules has been ascribed to inorganic pyrophos-
phate and polyphosphates [54,55]; however, the presence
of InsP6 in them, suggested by Schlatterer et al. [56], has
not yet been assessed. Electron-dense granules ascribed to
polyphosphate deposits have been also described, though
in lesser abundance, in the cytosol, nucleus and mitochon-
dria of D. discoideum [55]. As the overall Ca2+:InsP6 molar
ratio in D. discoideum amoebae is less than 1 [53], phytate
deposits can be expected to be formed mostly by magne-
sium phytate, irrespective of their localisation. If indeed
localised in the acidic ‘‘mass-dense granule’’ vacuoles, the
InsP6 solid(s) would be at equilibrium with signiﬁcant con-
centrations of the soluble compound. This would both
make the InsP6 pool a metabolically active one, and allow
the compartment’s osmolarity to be regulated through the
pH-dependent solubilisation/precipitation of InsP6.
3.5. Predictions for InsP6 in vesicular compartments
and under extracellular conditions
The pKs0 of calcium phytate is very high. Therefore the
set of equilibria described in this work and the previous one
[25] allow no soluble InsP6 under conditions that include
physiological pH and extracellular concentrations of free
Ca2+ and Mg2+. Being present at concentrations similar
to those of Ca2+, Mg2+ has no impact on the system, so
InsP6 is predicted to be entirely in the form of solid calcium
phytate. This is basically the case of the only known system
that displays extracellular accumulation of InsP6, namely
the larva of the cestode parasite Echinococcus granulosus
[19,20]. However, a soluble extracellular InsP6 pool has
also been suggested to exist in mammals: although widely
varying according to diet, InsP6 levels in human or rat
plasma have been reported to reach around 0.5 lM
[58,59]. Our data predict that this extracellular pool will
be associated with carrier proteins. A further important
consequence of our results is that experiments in which
exogenous InsP6 is added to cells in culture (see for exam-
ple [60–62], out of an extensive literature) have to be exam-
ined with caution. The two obvious possibilities are: i) cells
are being fed particulate calcium phytate, with concomitant
lowering of the Ca2+ concentration, and possibly also pH,
of the medium (when using sub-millimolar InsP6 concen-
trations), and ii) the medium is being depleted of free
Ca2+ and Mg2+ through complexation in solution (when
millimolar InsP6 doses are used). A third possibility (only
likely to apply for InsP6 concentrations in the lM range)
is that the medium may contain proteins with suﬃcient
InsP6-binding capacity as to keep it soluble.
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problems associated with InsP6
Phytate has long been recognised to interfere with the
absorption of Zn, Fe, and Ca in the gut (reviewed inFig. 4. A ‘‘user’s guide’’ to InsP6 in the presence of calcium and magnesium. T
reported in this work and in [25], in the presence of Mg2+ (a–c) or Ca2+ (d–g)
values (above pH 7.5) are identical to that shown for pH 7.5. The ‘‘frontier li
present is predicted to exist as a solid. Predictions were obtained by means of
addition, the validity of the predictions may be limited by the potential precipit
Na+/Mg2+, which have not been studied.[63]). Our data provide a rationale for explaining the eﬀect
on Ca, and possibly on the remaining metals mentioned.
The bulk of the phytate counterions in cereals is accounted
for by Mg and K [17,18]. Under highly acidic digestion
conditions in the stomach (pH 1–2), these InsP6 salts arehe solubility behaviour of InsP6, as predicted by the equilibrium equations
, is plotted for diﬀerent pH values; plots for the Mg2+ system at basic pH
nes’’ drawn correspond to conditions in which either 1% or 99% of InsP6
the HySS software, and are valid for I = 0.15 M NaClO4 and 37.0 C. In
ation, at high InsP6 concentrations, of salts containing Na
+, Na+/Ca2+ or
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approximately 4 mol of Mg per mol of InsP6 (Max Tate,
University of Adelaide, personal communication, based
on data in [18]); therefore almost any Ca or additional
Mg in the meal would put the system under conditions of
divalent metal excess with respect to InsP6. In consequence,
under duodenal conditions (pH 6–7), InsP6 is predicted to
(re-)precipitate. Our data predict that this precipitation will
take virtually all Ca2+ present (plus enough Mg2+ as to
complete the 5:1 M2+:InsP6 ratio). In other words, the
acidiﬁcation-neutralisation cycle in vertebrate digestion
allows cations that form relatively more soluble solids with
phytate to be replaced by those that form less soluble sol-
ids. Thus it may be precipitation, and not complexation
in solution, that is the most likely reason for Ca malabsorp-
tion by phytate. Although pKs0 values for the correspond-
ing solids are not yet available, the same mechanism
probably applies to malabsorption of Fe and Zn.
3.7. A ‘‘user’s guide’’ for the experimentation with InsP6
The data in this paper provide a few simple ‘‘rules of
thumb’’ to keep experiments involving InsP6 within reason-
ably physiological conditions. When mimicking cytosolic/
nuclear conditions, total Mg2+ should be set at a concen-
tration exceeding (by at least 0.5 mM) ﬁve times the con-
centration of InsP6; obviously, additional Mg
2+ must be
included when in the presence of further Mg2+ complexat-
ing agents such as ATP. In addition, total InsP6 concentra-
tions must be kept below 49 lM, unless working with
particulate phytate is desired and/or a substantial InsP6-
binding capacity (in proteins or membranes) is expected.
In order to imitate extracellular or vesicular system condi-
tions, a millimolar-range excess of Ca over ﬁve times the
molar amount of InsP6 present must be included. More-
over, it must be borne in mind that InsP6 will be present
in solid form (generally as a very ﬁne precipitate), except
for the fraction of it that may be bound by proteins.
Many experiments and procedures require conditions
other than those mentioned above. These include the prepa-
ration of stock solutions, the extraction of InsP6 from
biological samples, experiments mimicking intestinal condi-
tions, and assays of phytase activity. As mentioned, the mul-
tiple equilibrium constants involved can only be put to
practice with the help of specialised software, and even so,
with some technical diﬃculties. We have thus put together
a series of plots that summarise the solubility behaviour of
InsP6 in the presence of Ca
2+ and Mg2+ (Fig. 4). In these
plots, the frontiers between solubility and precipitation are
given in terms of total concentrations of InsP6 and metal.
Overall, for each given condition, the area of dominance of
solid phytate in the plots is wedged within the region of full
solubility, which encompasses both low and high InsP6
concentrations. However, for Ca2+ at neutral and alkaline
pH, the low-[InsP6] solubility region does not exist, reﬂecting
that as long as enoughmetal is present, even very low concen-
trations of phytate are insoluble. For Mg2+ at neutral andalkaline pH, the low-[InsP6] solubility region corresponds
to the dominance of Mg5(H2L), and it has therefore a
straight-line limit at [InsP6] = 49 lM.
The plots in Fig. 4 are given in terms of total metal ion.
For neutral and alkaline pH, free cation can be calculated
as total cation minus ﬁve times total InsP6; when [M
2+]total
is less than 5 · [InsP6]total, free divalent cations are absent.
It is important to bear in mind that in some situations it is
the concentration of freemetal ion that is ﬁxed. For example,
when InsP6 is parenterally administered, extracellular ﬂuids
can be expected to equilibrate with respect to (free) Ca2+:
thus once InsP6 precipitates, the local total ‘‘concentration’’
of Ca2+ will be equal to the overall physiological [Ca2+]free
plus the ﬁve times the local InsP6 ‘‘concentration’’. Similarly,
when dialysis of InsP6 against Ca
2+- or Mg2+-containing
media is attempted, free metal equilibrates between the two
compartments, and InsP6 precipitation takes place.
Conditions including both Ca2+ and Mg2+ are diﬃcult
to summarise. However, a simple rule is that within domi-
nance ranges of calcium phytate (Fig. 4d–g), the additional
inclusion of Mg2+ will not alter the system, except under
the very special set of conditions depicted in Fig. 3b.
Another rule of thumb is that, at the same total divalent
cation concentration, Ca2+–Mg2+ systems will be less solu-
ble than the corresponding Mg2+-only systems.
Our data are derived from constants measured in the
presence of 0.15 M NaClO4. Including K
+ instead of
Na+ does not change the systems signiﬁcantly ([64] and
our unpublished results). However, changes in ionic
strength are expected to alter the systems, with higher ionic
strength generally enhancing solubility and viceversa.Acknowledgements
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